ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
Koyama T, Ogawara K, Kasamatsu A, Okamoto A, Kasama H, Minakawa Y, Shimada K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
Koyama T, et al. Among authors: kasamatsu a.
Cancer Med. 2015 May;4(5):759-69. doi: 10.1002/cam4.418. Epub 2015 Jan 30.
Cancer Med. 2015.
PMID: 25644496
Free PMC article.